These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36389681)

  • 1. Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients.
    Wang Y; Liu Y; Zhang C; Zhang C; Guan X; Jia W
    Front Immunol; 2022; 13():1028937. PubMed ID: 36389681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial RNA modification-based signature to predict prognosis of lower grade glioma: a multi-omics exploration and verification study.
    Zhou X; Ling Y; Cui J; Wang X; Long N; Teng W; Liu J; Xiang X; Yang H; Chu L
    Sci Rep; 2024 Jun; 14(1):12602. PubMed ID: 38824202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization.
    Zhang X; Sun X; Guo C; Li J; Liang G
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C252-C268. PubMed ID: 37982173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
    Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
    Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA4-Mediated Immunosuppression in Glioblastoma is Associated with the Infiltration of Macrophages in the Tumor Microenvironment.
    Guan X; Wang Y; Sun Y; Zhang C; Ma S; Zhang D; Li D; Jia W
    J Inflamm Res; 2021; 14():7315-7329. PubMed ID: 34992419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Fibroblast-Related Prognostic Model in Glioma Based on Bioinformatics Methods.
    Zhang H; Huang Y; Yang E; Gao X; Zou P; Sun J; Tian Z; Bao M; Liao D; Ge J; Yang Q; Li X; Zhang Z; Luo P; Jiang X
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
    Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioma hexokinase 3 positively correlates with malignancy and macrophage infiltration.
    Liang T; Zhou X; Wang Y; Ma W
    Metab Brain Dis; 2024 Jun; 39(5):719-729. PubMed ID: 38687460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
    Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
    BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis related genes based prognostic model of glioma patients developed by multi-omics approach.
    Liu Z; Fan H; Liu X; Liu C
    Discov Oncol; 2024 Jul; 15(1):296. PubMed ID: 39033204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of m
    Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
    Front Immunol; 2022; 13():955848. PubMed ID: 36203569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.